A New Parameter Derived From DSA to Evaluate Cerebral Perfusion

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorXi'an No.3 Hospital

About this trial

This observational study focus on a new parameter of cerebral perfusion derived form digital substraction angiography.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Cerebral ischemia

patients undergone DSA

Disqualifiers

None

Trial population

the study population is from primary care clinic

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

30,000 Participants
are grouped into 3 trial groups
Group A: good perfusion in DSA
Group B: middle perfusion in DSA
Group C: poor perfusion in DSA

Trial outcomes

Primary outcomes

1

the outcomes between good perfusions and poor perfusions

Results are reported as odds ratios (ORs) with 95% confidence intervals (CIs).

Time frame
3 months to 2 years

Secondary outcomes

1

the outcomes between good perfusions and middle perfusions

Results are reported as odds ratios (ORs) with 95% confidence intervals (CIs).

Time frame
3 months to 2 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.